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ABSTRACT: A comprehensive understanding of the mecha-
nisms of interaction between proteins or peptides and
nanomaterials is crucial for the development of nanomaterial-
based diagnostics and therapeutics. In this work, we system-
atically explored the interactions between citrate-capped gold
nanoparticles (AuNPs) and islet amyloid polypeptide (IAPP),
a 37-amino acid peptide hormone co-secreted with insulin
from the pancreatic islet. We utilized diﬀusion-ordered
spectroscopy, isothermal titration calorimetry, localized surface
plasmon resonance spectroscopy, gel electrophoresis, atomic
force microscopy, transmission electron microscopy (TEM), and molecular dynamics (MD) simulations to systematically
elucidate the underlying mechanism of the IAPP−AuNP interactions. Because of the presence of a metal-binding sequence motif
in the hydrophilic peptide domain, IAPP strongly interacts with the Au surface in both the monomeric and ﬁbrillar states.
Circular dichroism showed that AuNPs triggered the IAPP conformational transition from random coil to ordered structures (α-
helix and β-sheet), and TEM imaging suggested the acceleration of IAPP ﬁbrillation in the presence of AuNPs. MD simulations
revealed that the IAPP−AuNP interactions were initiated by the N-terminal domain (IAPP residues 1−19), which subsequently
induced a facet-dependent conformational change in IAPP. On a Au(111) surface, IAPP was unfolded and adsorbed directly onto
the Au surface, while for the Au(100) surface, it interacted predominantly with the citrate adlayer and retained some helical
conformation. The observed aﬃnity of AuNPs for IAPP was further applied to reduce the level of peptide-induced lipid
membrane disruption.
■ INTRODUCTION
Islet amyloid polypeptide (IAPP) is an amyloidogenic peptide
involved in the pathogenesis of type II diabetes (T2D), an
epidemic disease worldwide that is associated with the self-
assembly and deposition of ﬁbrillar plaques in the pancreatic
islets.1−7 Physiologically, IAPP is a 37-amino acid peptide
hormone that is co-secreted with insulin and involved in
glycemic regulation.6 In a manner similar to those of other
amyloid peptides, IAPP contains a hydrophobic C-terminal
domain that governs ﬁbrillation kinetics and a hydrophilic
domain at the N-terminal domain that assists with structural
stability. The driving force for IAPP self-assembly into amyloid
ﬁbrils is ascribed to hydrophobic interactions and hydrogen
bonding in the core amyloidogenic region (SNNFGAILSS,
IAPP 20−29) at the C-terminal domain.8 A similar ﬁbrillation
mechanism has also been found in many other amyloid
peptides and/or proteins such as those related to Alzheimer’s
disease and Parkinson’s disease.9 Under normal conditions,
IAPP is inherently disordered, with self-assembly being
inhibited by insulin and other chaperones.7,10 However,
overproduction of β-sheet rich IAPP ﬁbrils at the pancreatic
islet has been found in 90% of T2D individuals, in which the
deposition of ﬁbrillar plaques and associations with the cell
membranes are related to the apoptosis and loss of pancreatic
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β-cells.2,7 Much eﬀort has been made to design amyloid
inhibitors to suppress IAPP ﬁbrillation.11−16
Amyloid peptides in their oligomeric9,17−21 or ﬁbrillar22−25
forms have been reported to be involved in disease pathologies
and cytotoxicity through interactions with cellular membranes.
During T2D, IAPP has been proposed to play an important
role in ion channel formation and nonspeciﬁc disruption of
lipid membranes, which disturbs homeostasis and results in β-
cell apoptosis.26−29 Because of the presence of lysine (K1),
arginine (R11), and histidine (H18) residues, the N-terminal
domain (residues 1−19) carries a net positive charge under
physiological conditions. Previous research using phosphatidyl-
glycerol (PG)- and phosphatidylserine (PS)-based lipid models
has shown that the positively charged N-terminal domain can
initiate binding of IAPP to anionic lipids, causing IAPP to adopt
an α-helical conformation on the negatively charged sur-
face.30−33 Similar conformational changes have been shown to
be a key driving force for the intermolecular recognition
necessary for the formation of β-sheet rich amyloid.17,21,34−36 A
high concentration of localized amyloid peptides can integrate
on lipid bilayers and alter the amyloid formation pathway.21,31
Over the past decade, nanomaterials have found broad
applications in the ﬁeld of diagnostics and therapeutics because
of their stability, large surface area, controllable morphology,
and unique physical properties.37,38 Understanding the
fundamental molecular interactions at the bio−nano interface
is essential to extending the current applications of nanoma-
terials. Indeed, the association of biological molecules such as
proteins, peptides, and nucleic acids with nanomaterials is a
complex process, because multiple interactions can be
cooperatively involved in binding. The presence of nanoparticle
(NP) surfaces can induce changes in the secondary structure of
proteins, resulting in an increased diversity and complexity of
protein structures at the interface, which makes it more
complicated to understand the protein−NP interaction at the
molecular level.39−42 Of particular interest is the interaction
between amyloid peptides and NP surfaces, with NPs of
diﬀerent sizes and surface compositions having been reported
to govern the kinetic processes of peptide ﬁbrillation, and its
related cytotoxicity.43−47 NP-induced inhibition or acceleration
of amyloid ﬁbrillation has been reported. These processes are
inﬂuenced by multiple factors, including the size, shape, surface
charge, and hydrophobicity of NPs.43,48−53
In this work, the interaction between IAPP and citrate-
capped gold NPs (AuNPs) is studied by combining synergistic
experiments and all-atom simulations. We anticipate that
understanding the IAPP−AuNP interaction and its eﬀects on
IAPP self-assembly will help reveal the mechanisms of
nanomaterial−amyloid peptide interactions at the molecular
level and may open interesting directions for the discovery of
new agents that interfere with the ﬁbrillation process.
■ RESULTS AND DISCUSSION
Observation of the Strong Aﬃnity of IAPP for AuNPs.
As shown in Scheme 1a, the peptide sequence of IAPP consists
of a hydrophilic N-terminal domain (residues 1−19) that can
interact with the cell membrane and a hydrophobic
amyloidogenic core (residues 20−29) at the C-terminal domain
that promotes peptide ﬁbrillation. Interestingly, residues that
can bind to the Au surface, including lysine (K1), cysteine (C2
and C7), asparagine (N3 and N14), arginine (R11), and
histidine (H18), are mostly located within the N-terminal
domain of IAPP.54,55 These multiple binding sites may initiate
strong binding of IAPP to the AuNP surface, which is expected
to cause IAPP deformation and modulate the nucleation−
growth pathway in parallel with the peptide self-assembly
process (route 1, Scheme 1b).53 Moreover, because the Au-
binding sequence of IAPP is located at the N-terminal domain,
which is exposed on the ﬁbril surface, preformed ﬁbrillar
nanostructures would also interact with AuNPs and induce
particle alignment (route 2).
We used proton diﬀusion-ordered nuclear magnetic reso-
nance spectroscopy (1H DOSY-NMR or DOSY) to examine
the aﬃnity of IAPP for AuNPs. DOSY is a powerful tool for
investigating molecular interactions by measuring the diﬀusion
coeﬃcients of solute molecules,56 which allowed us to
Scheme 1. (a) Schematic View of the Sequence of IAPP, in Which the N-Terminal Domain Binds to the Cell Membrane and the
Amyloidogenic Core (residues 20−29) Dictates Self-Assembly of Unstructured Monomers into β-Sheet Rich Amyloid Fibrils,
and (b) a Proposed Schematic Displaying the Two Routes of IAPP−AuNP Interactiona
aRoute 1, acceleration of IAPP nucleation and ﬁbril growth during the self-assembly process upon interaction with the AuNP surface. Route 2,
preformed IAPP ﬁbrils inducing the alignment of AuNPs. Note that routes 1 and 2 can occur in parallel once IAPP is dissolved in buﬀer.
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demonstrate the binding of IAPP to 2 nm AuNPs. As shown in
Figure 1, a series of spin echo spectra were measured with
diﬀerent pulsed ﬁeld gradient strengths, and signal decays were
analyzed to extract a set of diﬀusion coeﬃcients (D). The
DOSY spectra of IAPP were acquired using optimized
parameters for a maximal decay of ∼95% to be observed.
The diﬀusion coeﬃcient was calculated using the relative
intensities in the region of 0.70−1.25 ppm, which in general
corresponded to the α- and β-protons of the IAPP peptide
(Figure 1 and Figure S1). Compared to free IAPP, which had a
diﬀusion coeﬃcient of 3.8 × 10−10 m2 s−1 in solution, the
diﬀusivity of IAPP in the presence of 2 nm AuNPs was reduced
to 1.5 × 10−10 m2 s−1, indicating that the binding of IAPP to
AuNPs reduces the extent of Brownian motion because of the
larger construct. To determine which part of IAPP was involved
in binding to AuNPs, a series of one-dimensional Carr−
Purcell−Meiboom−Gill (CPMG) spectra were recorded for
IAPP in solution and AuNP-bound IAPP (data not shown).
While T2 remains almost the same for most IAPP peaks, it was
observed that a number of peaks assigned to the N-terminal
residues of IAPP (C2/N3, T4, A5, and T6)57,58 exhibited a
signiﬁcant increase in spin−spin relaxation (e.g., T2 relaxation
times for T6 decreased from 23 to 19 ms) in the presence of 2
nm AuNPs. In addition, many other peaks were less attenuated
than those corresponding to N-terminal residues, indicating the
stronger binding to the latter. The aﬃnity of IAPP for the
AuNP surface was demonstrated by the mobility of AuNPs (5
nm) in a peptide solution during agarose gel electrophoresis. As
shown in Figure S2, it is clear that the reduced mobility of
AuNPs (displayed as red bands) was observed at a peptide
concentration as low as 0.1 μM. This eﬀect can be explained by
the partial charge neutralization of AuNPs by IAPP, because
IAPP carries two positive charges at pH 7.5, from lysine and
arginine, at the N-terminal domain, while citrate-capped AuNPs
are negatively charged (Table S1). When IAPP binds, the
surface charge density of AuNPs is reduced and migration
thereby blocked.
The IAPP−AuNP interactions and peptide-triggered AuNP
aggregation were demonstrated by the peak shift of the
plasmonic spectra. According to the DLVO theory, colloidal
particles in aqueous solution are stabilized by electrostatic
repulsion and steric eﬀects.59 Here, the surface charge shielding
of AuNPs upon the adsorption of IAPP resulted in immediate
AuNP aggregation as observed by UV−vis spectroscopy
(Figure S3a−c) with a red-shift of local surface plasmon
resonance (LSPR) peaks being noted. A large red-shift was
found for larger NPs (20 nm), for which an IAPP concentration
as low as 0.31 μM was able to trigger an ∼80 nm peak shift. A
further increase in IAPP concentration led to a decrease in the
peak shift (Figure S3d), possibly because the increased level of
deposition of IAPP on the AuNP surface provides a steric eﬀect
to reduce the interparticle distance.
To assess the thermodynamic properties of IAPP−AuNP
interactions, isothermal titration calorimetry (ITC) was
performed to determine the binding aﬃnity, enthalpy changes
upon binding, and binding stoichiometry. As shown in Figure
S4, the titration of IAPP into the AuNP (5 nm) solution
showed that the binding of IAPP to AuNP surfaces was a
spontaneous exothermic process (ΔH = −6.6 ± 0.11 kcal/
mol). The sigmoidal titration curve (Figure 1c) was generated
by subtracting the result from the control data [titration of
IAPP into water (Figure 1d)] to remove the cooperative eﬀect
of inter-IAPP interactions and the desolvation/dilution eﬀect
during peptide titration. Actually, the control data show no
noticeable heat change, indicating that the strong exothermic
response was mainly attributed to the IAPP−AuNP interaction.
Figure 1. Investigation of the interactions between IAPP and citrate-capped AuNPs. (a) Schematic view of the reduced mobility of IAPP caused by
the binding of AuNPs. This was demonstrated by acquiring the DOSY spectra at diﬀerent pulsed ﬁeld magnetic strengths: (top) IAPP and (bottom)
IAPP/AuNP (2 nm). (b) Via a plot of the integrated NMR intensity vs magnetic ﬁeld gradient, the diﬀusion coeﬃcient (D) was calculated, showing
the reduced molecular mobility of IAPP in the presence of 2 nm AuNPs. (c) Curve ﬁtting of the ITC raw data by a single set of binding sites,
showing the interaction of IAPP with 5 nm AuNPs was a spontaneous exothermic process. The result was subtracted from the (d) control data
(titration of IAPP into water).
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This ITC titration curve ﬁtted well with a single-site binding
process with a nonlinear least-squares regression, allowing the
average number of binding sites (N), dissociation constants
(KD), and entropy (ΔS) and enthalpy (ΔH) changes to be
determined. A KD of ∼9.18 × 10
6 M−1 was observed, which was
close to the binding limit for the complexation of the protein or
peptide with AuNPs.60,61 The high estimated number of
binding sites (N ∼ 600) could suggest a multilayered binding of
IAPP to the AuNPs. In fact, the presence of a multilayer
construct has been reported previously for the binding of β2m
amyloid peptides on N-isopropylacrylamide/N-tert-butylacryla-
mide NPs, which was attributed to the conformational
restriction of the peptide on the particle surface.43 However,
the result was not conclusive because AuNP agglomeration and
peptide conformation changes could occur during the titration
process. In a control experiment, the binding aﬃnity of the
IAPP amyloidogenic region (residues 20−29) for AuNPs was
found to be much weaker, with the heat change acquired by
ITC being signiﬁcantly smaller (Figure S5). Moreover, the
addition of freshly dissolved IAPP 20−29 peptide or its ﬁbrillar
form did not cause any LSPR peak shift from the 20 nm AuNP
solution (Figure S6). These results suggest that the N-terminal
domain of IAPP plays a crucial role in the IAPP−AuNP
interaction, as conﬁrmed by theoretical simulations discussed
below.
It is known that the hydrophobic core of IAPP is embedded
in its ﬁbrillar structure, while the hydrophilic N-terminal
domain is located at the outer surface.62 Therefore, it is
expected that Au-binding sites would be exposed to the
aqueous environment in the ﬁbrillar form. As a result,
preformed IAPP ﬁbrils (Scheme 1) can interact with citrate-
capped AuNPs of diﬀerent sizes and induce NP assembly on
the ﬁbrils, as displayed by TEM (Figure 2a−c) and atomic force
microscopy (AFM) (Figure 2d−f). Using AFM, a packing of 5
nm AuNPs on the peptide ﬁbril was observed to have an
average height of 4−6 nm and a particle−particle spacing of
∼34 nm (Figure 2f). Unlike the freshly dissolved IAPP, the
IAPP ﬁbrils did not cause large plasmonic peak shifts of the
AuNPs, presumably because the immobilization of AuNPs on
ﬁbrils prevented NP aggregation (Figure S7).63 In situ
nucleation of AuNPs in the presence of IAPP ﬁbrils was
performed to show the strong interactions between AuNPs and
peptide ﬁbrils, although it remains unclear whether the
formation of Au−ﬁbril hybrid structures was due to a
templating eﬀect or a post-synthesis adsorption. As shown in
Figure S8a, AuNPs around 16 ± 3 nm in size were
preferentially formed on the IAPP ﬁbril after reducing Au
ions in 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
(HEPES) buﬀer. A dark ﬁeld scanning transmission electron
microscopy (DF-STEM) image (Figure S8b) and the
corresponding elemental analysis by energy-dispersive X-ray
spectroscopy (EDS) (Figure S8c) conﬁrmed Au formation on
the IAPP ﬁbrils.
To gain insight into the interaction mechanisms and
conformational changes of IAPP during the adsorption on
citrate-capped AuNPs, molecular dynamics (MD) simulations
were performed on the monomeric and preformed ﬁbrillar
structures of IAPP (Figure S9). The simulations indicated that
IAPP monomers exhibited a facet-dependent conformational
preference upon binding to citrate-capped Au(100) and
Au(111) surfaces (Figure 3a). Starting from the helical IAPP
conformation that was characteristic for a surface-adsorbed
Figure 2. (a−c) TEM images showing the assembly of citrate-capped Au particles on preformed IAPP ﬁbrils: 5 nm AuNPs, 10 nm AuNPs, and 20
nm AuNPs, respectively. (d and e) AFM topographic images in tapping mode and (f) the corresponding height proﬁle obtained from panel e
showing the binding of 5 nm AuNPs on the IAPP ﬁbril.
Chemistry of Materials Article
DOI: 10.1021/acs.chemmater.6b04144
Chem. Mater. 2017, 29, 1550−1560
1553
state and independent of the starting peptide orientation and
Au facets, all simulations revealed that the initial contact
between IAPP and the Au surface occurred via the N-terminal
domain. This was likely due to the strong electrostatic
attraction between the positively charged K1 residue and the
negative citrate layer. In the presence of the Au(100) surface,
IAPP largely retained its two helical regions, with some
unfolding seen in the loop region at H18. The peptide
interacted mostly with the citrate layer, where the helical
conformation was stabilized by interactions between cationic
K1 and H18 residues and the anionic citrate layer (Figure 3b).
Interestingly, the second helix within the amyloidogenic region
(residues 20−29) remained only partially folded and solvent-
exposed, which could allow further conformational transition
and subsequent ﬁbril growth. This behavior is consistent with
that seen for the binding of IAPP to anionic lipids, where the
formation of an α-helix between residues 5 and 22 has been
observed.30−33 Such a structure has also been postulated to be
the key conformational motif that facilitates intermolecular
recognition and amyloidogenesis.17,21,34−36 On the Au(111)
surface, IAPP monomers interacted more strongly with the Au
surface, driven by speciﬁc contacts between the amino acid
residues and exposed Au atoms (Figure 3f). This contributed to
the partial unfolding of helix 1 (residues 6−17) and complete
unfolding of the second helix (residues 20−29) (Figure 3a),
which is involved in the self-assembly and ﬁbril formation of
IAPP.8 Thus, the unfolding observed for the hydrophobic C-
terminal peptide domain in the presence of the Au(111) surface
would be favorable for inducing interpeptide interactions and
could promote ﬁbril formation. On the other hand, the ﬁbrillar
form of IAPP retained its conformation over the entire
simulation despite the exposed Au surface facet, suggesting
that the ﬁbril was stable in the presence of Au. This favorable
binding of IAPP ﬁbrils to Au surfaces is in agreement with the
TEM and AFM results shown in Figure 2. As for the IAPP
monomers, the adsorption of IAPP ﬁbrils on Au surfaces is
likely dominated by the N-terminal domain. However, the
binding relies on electrostatic interactions with the citrate
adlayer rather than direct contact with the Au surface (Figure
3d,e).
The role of water in the mechanisms of binding of IAPP to
the Au surfaces was also investigated (Figure S10). Simulations
showed a higher density of water on the Au(100) surface than
on the Au(111) surface. This eﬀect is due to the square
arrangement of Au atoms on Au(100) surfaces that can
facilitate structuring of water and marks a diﬀerence with the in-
plane quasi-hexagonal atomic arrangement of the Au(111)
surface. The more compact adsorbed water layer resulted in
Figure 3. MD results showing (a) the conformational preference (per residue) of IAPP monomers and ﬁbrils to adsorb on Au(100) and Au(111)
surfaces. Representative structures of IAPP interacting with each surface: (b) monomer−Au(100), (c) monomer−Au(111), (d) ﬁbril−Au(100), and
(e) ﬁbril−Au(111). The interactions between charged residues are colored blue, and the citrate adlayer within 3 Å of IAPP is shown. IAPP is colored
on the basis of its secondary structure: purple for helix, light blue for β-sheet, white for coil, and cyan for turn. Water molecules were omitted for the
sake of clarity. Contact persistence of speciﬁc regions of IAPP: (f) monomers and (g) ﬁbrils with the Au(111) (blue) and Au(100) (green) surfaces
and the citrate adlayer (shown as dashed lines for each surface).
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weaker (water-mediated) binding of IAPP to the Au(100)
surface, which was in agreement with other studies.64 The facet-
dependent structuring of water on Au surfaces had similar
eﬀects in both simulations for IAPP monomers and ﬁbrils.
Citrate molecules also exhibited stronger adsorption on the
Au(100) facet than on the Au(111) facet (Figure S10), which
resulted in a weaker IAPP−Au interaction in the former. Upon
comparison of IAPP monomers to ﬁbrils, it is worth noting that
the small decrease in citrate density close to the Au(111)
surface, caused by the displacement of citrate molecules upon
binding, suggests a stronger binding of monomers rather than
ﬁbrils to the Au surface.
In summary, our results show that the IAPP−AuNP
interaction is dominated by the N-terminal domain of the
peptide, with the conformation of surface-adsorbed IAPP
determined by the exposed Au facets. Water/citrate-mediated
binding on the Au(100) facet led to the stabilization of a helical
conformation at the N-terminal domain, with slight unfolding
at the amyloidogenic helix, while a complete unfolding at the
amyloidogenic region of IAPP on the Au(111) facet was
observed because of direct binding to the Au surface.
Interestingly, although both binding mechanisms showed the
exposure of the amyloidogenic C-terminal domain of the IAPP
monomers, the stronger deformation of the IAPP structure
Figure 4. (a) IAPP ﬁbrillation kinetics in solution recorded by CD. The arrows show a decreasing intensity of the signal at 200 nm and an increasing
intensity of the signal at 220 nm as a function of time, representing the conformational change. (b) CD spectra of IAPP with and without 5 nm
AuNPs (t = 0 min), showing the rapid conformational change induced by AuNPs. (c) CD kinetics of IAPP (25 μM) in the presence of 5 nm AuNPs
(20.8 nM). (d) CD intensity at 220 nm, showing the accelerated formation of ordered structures (i.e., α-helices and β-sheets) by 5 and 10 nm
AuNPs but not smaller AuNPs (2 nm). The signals were subtracted from the values at time zero. (e and f) CD kinetics of IAPP (25 μM) in the
presence of 10 and 2 nm AuNPs, respectively. The ﬁnal concentrations of the AuNPs were 2.08 and 20.8 nM, respectively. TEM images of IAPP
solution in the absence (g−i) and presence (j−l) of 5 nm AuNPs (20.8 nM) at diﬀerent ﬁbrillation time points (0, 4, and 8 h from left to right,
respectively).
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could suggest the Au(111) surface to be a stronger ﬁbril
promoter. Previous studies have demonstrated the increase in
(111)/(100) dominant facet ratios with an increase in AuNP
size.65 Therefore, the IAPP adsorption and ﬁbrillation kinetics
could potentially be mediated by a change in the size and
morphology of NPs.
Regulation of IAPP Fibrillation Kinetics by the
Presence of AuNPs. Similar to other amyloid peptides, the
amyloidogenesis of IAPP is a multistep process that is highly
dependent on the formation of energetically unfavorable nuclei.
In general, the nucleation−growth process of IAPP ﬁbrillation
is slow and requires a high concentration of monomers. This
could be observed by the utilization of the widely used
thioﬂavin T (ThT) assay, in which the ﬂuorophore targets the
formation of β-sheet structure (Figure S11a). Amyloid
formation proceeded slowly before a suﬃcient population of
nuclei were formed, during which only trace amounts of
amyloid ﬁbrils could be found. Once a critical concentration of
nuclei was reached, peptide assembly proceeded rapidly for
conversion into ﬁbrils, evidenced by an exponential increase in
ThT ﬂuorescence. This indicated the formation of mature
ﬁbrils, which was observed by TEM to have an average width of
9.1 ± 1.8 nm and a micrometer length (Figure S11b).8,66 The
ﬁbrillation kinetics were found to be strongly dependent on
IAPP concentration, with a higher concentration of IAPP
resulting in a shorter lag phase and higher ThT ﬂuorescence.
The eﬀect of AuNPs on IAPP amyloidogenesis was
investigated by considering the strong aﬃnity of IAPP for
AuNPs, and the facet-dependent adsorption mechanisms
suggested by the MD simulations. Circular dichroism (CD),
which is commonly used to study the secondary structure of
peptides and/or proteins, was used to monitor the IAPP
conformational changes during the ﬁbrillation process. In
solution, IAPP transforms from random coil into β-sheet during
the growth process, with typical CD signals at 200 and 220 nm
being observed, respectively (Figure 4a).
Interestingly, we observed a conformational change from
random coil (200 nm) into a helical (205 and 222 nm)
intermediate structure in the presence of 5 nm AuNPs (Figure
4b,c and Figure S12a), which were dominated by the (111)
facets.45 We also demonstrated that this eﬀect was not due to
the absorbance of AuNPs or spectral overlap between AuNPs
and IAPP (Figure S12b,c). In addition, the amounts of ordered
structures (i.e., α-helices and β-sheets) were found to increase
in the presence of 5 nm AuNPs as the CD intensity at 220 nm
was shown to be higher (Figure 4d and Figure S13). This
agrees with the TEM results that show extensive ﬁbrillar
bundles after 4 h in the presence of 5 nm AuNPs (Figure 4g−l).
AuNP-promoted ﬁbrillation was also demonstrated by TEM at
shorter ﬁbrillation periods [i.e., 10, 30, and 60 min (Figure
S14)]. These results suggested that the presence of AuNPs
could increase the level of ordering of amyloid structures and
accelerate the ﬁbrillation process, which could be rationalized
by the fact that the local concentration of IAPP increases upon
binding of IAPP to the NP surface. The increased eﬀective
concentration of IAPP at the surface of the AuNPs then favors
nucleation and promotes ﬁbrillation. This eﬀect has been
reported in the literature where liquid−solid interfaces
exhibited speciﬁc and signiﬁcant eﬀects on promoting amyloid
ﬁbrillation by forming a critical nucleus for the nucleation of
peptide ﬁbrils at an interface.21,43 It is therefore expected that
AuNPs with a larger surface area may exert a stronger inﬂuence
on IAPP ﬁbrillation. Indeed, 10 nm AuNPs have shown a
capability to accelerate ﬁbrillation at a much lower concen-
tration [∼2.08 nM (Figure 4d,e, Figure S13, and Figure S15a−
c) similar to that of 5 nm AuNPs (∼20.8 nM), supporting the
Figure 5. (a) Schematic of IAPP-induced lipid membrane disruption, which could be inhibited by AuNPs. (b) TEM image showing the interaction
of IAPP with POPC/POPG (50:50) liposomes that disrupted the lipid membranes. (c and d) Time-dependent dye leakage from CF-encapsulated
POPC/POPG (50:50) liposomes triggered by IAPP oligomers and ﬁbrils, respectively, in the presence of AuNPs (5 nm) at diﬀerent concentrations.
The concentrations of IAPP oligomers and ﬁbrils were 0.31 and 1 μM, respectively. Fluorescence was recorded with excitation at 485 nm and
emission at 520 nm; 100% CF release was obtained by adding Triton X-100 to the solution. (e) Fluorescence emission of NR (10 μM) in the
liposome (DMPC/DMPG, 50:50)/IAPP solution. The control sample contains liposomes and NR dye, and the blank sample is the NR only
solution.
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conclusion of size-dependent IAPP−AuNP interactions. The
eﬀect of 2 nm AuNPs on IAPP ﬁbrillation was not obvious, and
some inhibitory eﬀect was observed (Figure 4d,f, Figure S13,
and Figure S15d−f). This was likely due to the smaller surface
area and the lack of a dominating (111) facet.67
The rapid formation of helical intermediate structures on the
Au surface could be another factor that promoted IAPP
ﬁbrillation. This hypothesis was also supported by MD
simulation, which showed a relatively stable helical structure
at the N-terminal domain for the adsorption of IAPP on Au
surfaces (Figure 3). Recent studies have demonstrated that
helical structures are on-pathway intermediates to the
formation of intermolecular β-sheets and subsequent amyloid
formation.9,68 In summary, we proposed that the strong binding
of AuNPs enhanced the local population of peptides and
favored the formation of an intermediate helix with exposed
amyloidogenic regions on the Au surface, promoting IAPP self-
assembly. NP-promoted amyloid ﬁbrillation was also observed
for short peptides (e.g., NNFGAIL from IAPP and GNNQ-
QNY from prion proteins).69,70 In these two cases, although
rapid oligomerization was triggered by the NP surfaces that
were densely packed with N-terminally bound peptides, the
surfaces did not alter the initial peptide conﬁgurations.
Inhibition of IAPP-Induced Lipid Membrane Disrup-
tion by AuNPs. The loss of lipid membrane integrity has been
considered as the major cytotoxic mechanism induced by
IAPP.26,36 The molecular basis of the lipid−IAPP interaction is
known to depend on the concentration and charge density of
the lipid membrane, which can occur over a physiologically
relevant range of anionic content.31 It is also known that IAPP
residues 1−19 are responsible for the membrane disrup-
tion.31,71 Because AuNPs have been shown to bind to the N-
terminal domain of IAPP, we hypothesized that AuNPs could
inhibit the association of IAPP with negatively charged lipid
membranes, preventing membrane disruption (Figure 5a). To
test this hypothesis, a liposome model composed of 1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) and
1-palmitoyl-2-oleoyl-sn-glycero-3-phospho(1-rac-glycerol)
(POPG) with 50% PG content was prepared by a typical
hydration method and size exclusion,29 to give liposomes with
an average size of 151 ± 1.7 nm (Figure S16a,b) and a surface
charge of −59.3 ± 4.0 mV. TEM imaging revealed the IAPP−
liposome interactions, in which the peptide can disrupt the
membrane surface (Figure 5b) and penetrate through the lipid
structure during growth into larger ﬁbrils (Figure S17).
To quantify the membrane disruption by IAPP and the
inhibitory eﬀect of AuNPs, a dye leakage assay was performed.
To this end, a high concentration (50 mM) of carboxy-
ﬂuorescein (CF), a self-quenching ﬂuorescent dye, was
encapsulated into the POPC/POPG liposomes. At such high
concentrations of CF, the emission was quenched, and the
recovery of ﬂuorescence was measured during the dye leakage
induced by IAPP (Figure S18). Because both the AuNPs and
lipid membranes are negatively charged, implying a passive
process for the AuNP−lipid interaction, the dye leakage from
the POPC/POPG liposomes was anticipated to be induced by
the IAPP−lipid interactions. As shown in Figure 5c, an
immediate release of CF from the liposome was triggered by
IAPP oligomers (0.31 μM), whereas reduced and delayed dye
leakage was observed in the presence of 5 nm AuNPs within
the experimental time frame, indicating that lipid membrane
disruption by IAPP could be inhibited by AuNPs. Similarly,
lipid membrane leakage could also be induced by IAPP ﬁbrils
(1 μM) with much less CF release (40%) within the
experimental time frame (Figure 5d), which also could be
inhibited by 5 nm AuNPs. It is noted that IAPP oligomers are
more eﬃcient in causing membrane leakage than IAPP ﬁbrils,
which is consistent with the ﬁndings that IAPP oligomers are
responsible for the cytotoxicity.17,19,21,68 The inhibition
eﬃciencies of AuNPs were concentration-dependent; i.e.,
higher AuNP concentrations led to an increased level of
inhibition. Because the AuNPs (5 nm) consist of (111) facet-
dominated surfaces, facilitating signiﬁcant conformational
changes of IAPP and large binding sites for surface interactions
(Figure 1c and Figure S9b),50,72 a strong inhibition of IAPP-
induced lipid membrane disruption was achieved by AuNPs.
The lipid membrane micropolarity was also tracked to
investigate the eﬀect of IAPP−AuNPs interactions on peptide-
induced membrane disruption. Here, an environmentally
sensitive ﬂuorescent dye Nile red (NR) was used, which
ﬂuoresces when bound to hydrophobic structures. It is reported
that the ﬂuorescence intensity of NR is substantially enhanced
in hydrophobic environments compared to that in hydrophilic
environments.71 As shown in Figure 5e, the presence of
DMPC/DMPG liposomes [156.4 ± 1.1 nm, −70.5 ± 4.5 mV
(Figure S16c,d)] signiﬁcantly increases the ﬂuorescence
emission of NR, indicating the hydrophobic dye was embedded
in the lipid bilayer of the liposome. A peak blue-shift of NR
emission from 650 to 625 nm was also noted in the liposome
solution compared to that in buﬀer, conﬁrming the
solubilization of NR by the lipid membrane. In the presence
of IAPP, the ﬂuorescence intensity of NR was reduced to 46%,
suggesting an increase in environment micropolarity. This is
because the penetration of IAPP into the lipid membrane might
lead to a looser packing of lipid molecules and the intrusion of
water, both of which can increase the polarity of lipid
membranes. In the presence of 5 nm AuNPs, the ﬂuorescence
was regained with an increasing AuNP concentration, implying
the integrity of the lipid membrane was maintained in the
presence of AuNPs.
■ CONCLUSIONS
Our combined experimental and computational simulation
study has demonstrated a strong interaction between full-length
IAPP and AuNPs, which is initiated by the hydrophilic N-
terminal domain, followed by a conformational change in a
facet-dependent manner. The binding of IAPP to AuNPs
induces the aggregation of AuNPs, with a stronger aggregation
being noted for larger NPs. Because IAPP−AuNP interactions
were shown to originate from the outer hydrophilic N-terminal
sequence rather than the amyloidogenic core sequence, the
exposed N-terminal domain of preformed IAPP ﬁbrils could
induce adsorption and/or assembly of AuNPs or direct in situ
Au nucleation on the ﬁbril surface.
The IAPP−AuNP interaction was observed to accelerate
IAPP ﬁbrillation by the preferential formation of ordered
structures, which can be partially ascribed to the AuNP-induced
formation of an intermediate helix and conformational
restructuring of the amyloidogenic region that consequently
promoted IAPP ﬁbrillation. This was supported by MD
simulations showing signiﬁcant conformational rearrangements
on Au(111) facets that are dominant in larger AuNPs. In
addition, the large surface area of AuNPs and high peptide
adsorption aﬃnity led to an increased local concentration of
peptide, thus triggering nucleation and further ﬁbril growth. By
using synthetic liposome models, we have demonstrated the
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inhibition of IAPP-triggered lipid membrane disruption by
implementing IAPP−AuNP interactions. We expect that
investigation of the availability of amyloid peptide/AuNP-
binding domains will provide a deeper understanding of the
responsible structural features for NP-driven ﬁbril formation.
This in turn will provide fundamental insight and guidelines for
controlling the interactions of biomolecules with NPs for
amyloid diseases.
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